Cargando…
Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
PURPOSE: To report a case of bacterial keratitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain linked to contaminated artificial tears in the United States. The ulcer was successfully treated without perforation or extracorneal spread. OBSERVATIONS: An 81-year-old patie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407592/ https://www.ncbi.nlm.nih.gov/pubmed/37560556 http://dx.doi.org/10.1016/j.ajoc.2023.101909 |
_version_ | 1785085999730130944 |
---|---|
author | Rezaei, Sina Steen, Daniel Amin, Sejal |
author_facet | Rezaei, Sina Steen, Daniel Amin, Sejal |
author_sort | Rezaei, Sina |
collection | PubMed |
description | PURPOSE: To report a case of bacterial keratitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain linked to contaminated artificial tears in the United States. The ulcer was successfully treated without perforation or extracorneal spread. OBSERVATIONS: An 81-year-old patient presented with a corneal ulcer of the right eye. The patient had a notable complex ocular history including glaucoma and corneal edema from corneal decompensation after prolonged retained lens fragment. Despite starting hourly fortified tobramycin and vancomycin eye drops, the infiltrate grew significantly by the next day. Bacterial culture grew Pseudomonas aeruginosa that was resistant to all tested antibiotics except for intermediate susceptibility to colistin and susceptibility to cefiderocol. Tobramycin-soaked collagen shields were applied daily for three days, and the patient was started on fortified colistin eye drops. The ulcer improved and, after seven weeks of therapy, the infiltrate resolved and resulted in a large central corneal scar. CONCLUSIONS AND IMPORTANCE: A combination of fortified colistin and tobramycin (administered via a combination of fortified eye drops and tobramycin-soaked collagen shields) appears to be an effective treatment option for extensively drug-resistant Pseudomonas aeruginosa corneal ulcers. |
format | Online Article Text |
id | pubmed-10407592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104075922023-08-09 Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears Rezaei, Sina Steen, Daniel Amin, Sejal Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of bacterial keratitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain linked to contaminated artificial tears in the United States. The ulcer was successfully treated without perforation or extracorneal spread. OBSERVATIONS: An 81-year-old patient presented with a corneal ulcer of the right eye. The patient had a notable complex ocular history including glaucoma and corneal edema from corneal decompensation after prolonged retained lens fragment. Despite starting hourly fortified tobramycin and vancomycin eye drops, the infiltrate grew significantly by the next day. Bacterial culture grew Pseudomonas aeruginosa that was resistant to all tested antibiotics except for intermediate susceptibility to colistin and susceptibility to cefiderocol. Tobramycin-soaked collagen shields were applied daily for three days, and the patient was started on fortified colistin eye drops. The ulcer improved and, after seven weeks of therapy, the infiltrate resolved and resulted in a large central corneal scar. CONCLUSIONS AND IMPORTANCE: A combination of fortified colistin and tobramycin (administered via a combination of fortified eye drops and tobramycin-soaked collagen shields) appears to be an effective treatment option for extensively drug-resistant Pseudomonas aeruginosa corneal ulcers. Elsevier 2023-07-28 /pmc/articles/PMC10407592/ /pubmed/37560556 http://dx.doi.org/10.1016/j.ajoc.2023.101909 Text en © 2023 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Rezaei, Sina Steen, Daniel Amin, Sejal Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
title | Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
title_full | Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
title_fullStr | Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
title_full_unstemmed | Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
title_short | Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
title_sort | successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407592/ https://www.ncbi.nlm.nih.gov/pubmed/37560556 http://dx.doi.org/10.1016/j.ajoc.2023.101909 |
work_keys_str_mv | AT rezaeisina successfultreatmentofanextensivelydrugresistantpseudomonalulcerassociatedwithcontaminatedartificialtears AT steendaniel successfultreatmentofanextensivelydrugresistantpseudomonalulcerassociatedwithcontaminatedartificialtears AT aminsejal successfultreatmentofanextensivelydrugresistantpseudomonalulcerassociatedwithcontaminatedartificialtears |